- Home
- FMX vs RGC Comparison
FMX vs RGC Comparison
Compare FMX & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMX
- RGC
- Stock Information
- Founded
- FMX 1890
- RGC 2014
- Country
- FMX Mexico
- RGC Hong Kong
- Employees
- FMX N/A
- RGC N/A
- Industry
- FMX Beverages (Production/Distribution)
- RGC Medicinal Chemicals and Botanical Products
- Sector
- FMX Consumer Staples
- RGC Health Care
- Exchange
- FMX Nasdaq
- RGC Nasdaq
- Market Cap
- FMX 34.9B
- RGC 38.6B
- IPO Year
- FMX 1998
- RGC 2021
- Fundamental
- Price
- FMX $91.05
- RGC $12.97
- Analyst Decision
- FMX Buy
- RGC
- Analyst Count
- FMX 5
- RGC 0
- Target Price
- FMX $107.20
- RGC N/A
- AVG Volume (30 Days)
- FMX 825.7K
- RGC 1.2M
- Earning Date
- FMX 07-28-2025
- RGC 06-30-2025
- Dividend Yield
- FMX 5.71%
- RGC N/A
- EPS Growth
- FMX N/A
- RGC N/A
- EPS
- FMX 0.30
- RGC N/A
- Revenue
- FMX $43,105,386,284.00
- RGC N/A
- Revenue This Year
- FMX $13.55
- RGC N/A
- Revenue Next Year
- FMX $9.34
- RGC N/A
- P/E Ratio
- FMX $27.81
- RGC N/A
- Revenue Growth
- FMX 9.82
- RGC N/A
- 52 Week Low
- FMX $81.08
- RGC $0.09
- 52 Week High
- FMX $114.33
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- FMX 25.90
- RGC 43.66
- Support Level
- FMX $89.60
- RGC $13.11
- Resistance Level
- FMX $92.56
- RGC $14.80
- Average True Range (ATR)
- FMX 2.43
- RGC 1.43
- MACD
- FMX -0.96
- RGC -0.01
- Stochastic Oscillator
- FMX 19.08
- RGC 3.72
About FMX Fomento Economico Mexicano S.A.B. de C.V.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.